Biomarkers of the peripheral blood, such as the neutrophil‐to‐lymphocyte ratio (NLR) or the C‐reactive protein (CRP), have been associated with COVID‐19 disease severity in patients both with or without cancer.11, 20, 21, 22, 23. Here, CRP is linked to cancer.